Table 1.
a Clinical characteristics of the GoKinD cohort | ||||||
---|---|---|---|---|---|---|
T1D with DN |
T1D without DN |
|||||
all |
female |
male |
all |
female |
male |
|
Number | 578 | 265 | 313 | 599 | 357 | 242 |
Age, years | 44±6 | 44±7 | 45±6 | 40±8 | 40±9 | 40±8 |
Duration, years | 32±8 | 32±8 | 32±8 | 26±8 | 26±8 | 26±8 |
HbA1c,% | 7.4±1.9 | 7.4±2.1 | 7.4±1.7 | 7.5±1.1 | 7.5±1.1 | 7.4±1.1 |
BMI | 25.7±5.3 | 25.2±5.7 | 26.1±4.9 | 26.0±4.4 | 25.7±4.7 | 26.6±3.7 |
Creatinine, mg/dl | 2.1±1.9 | 1.9±1.6 | 2.3±2.0 | 0.9±0.2 | 0.8±0.1 | 1.0±0.1 |
Cystatin, mg/l | 2.2±1.7 | 2.2±1.6 | 2.4±1.7 | 0.8±0.1 | 0.8±0.1 | 0.8±0.1 |
Cholesterol, mg/dl | 186.3±45.9 | 190.3±47.3 | 183.0±44.6 | 185.0±31.3 | 188.7±30.9 | 179.7±31.2 |
HDL, mg/dl | 53.6±17.3 | 59.3±18.2 | 48.9±15.1 | 59.1±15.9 | 64.8±15.5 | 51.0±12.4 |
Systolic BP, mm Hg | 131±19 | 130±20 | 133±18 | 118±12 | 116±12 | 122±12 |
Diastolic BP, mm Hg | 74±11 | 72±11 | 75±11 | 71±8 | 70±7 | 74±8 |
b Clinical characteristics of the African-American cohort | |||||||||
---|---|---|---|---|---|---|---|---|---|
T2D-ESRD |
HTN-ESRD |
ND controls |
|||||||
all |
female |
male |
all |
female |
male |
all |
female |
male |
|
Number | 284 | 176 | 108 | 284 | 126 | 158 | 282 | 132 | 150 |
Age, years | 64±10 | 65±11 | 62±9 | 54±15 | 56±16 | 52±14 | 50±10 | 50±10 | 49±10 |
Age of onset ESRD | 60±10 | 62±11 | 58±10 | 48±16 | 50±17 | 47±15 | − | − | − |
Age of onset HTN | − | − | − | 33±12 | 31±12 | 35±11 | − | − | − |
Age of onset T2D | 43±11 | 43±11 | 43±11 | − | − | − | − | − | − |
BMI | 29.3±7.3 | 29.9±7.8 | 28.5±6.3 | 26.5±7.3 | 27.5±8.4 | 25.8±6.2 | 29.3±6.8 | 31.2±7.6 | 27.6±5.5 |
All data are means ± SD.
T2D = Type 2 diabetes; ESRD = end-stage renal disease; HTN = hypertension; ND = nondiabetic controls.